ISRG Earnings
Upcoming earnings date and last 8 quarters of EPS surprise.
Next Earnings
EPS Surprise — Last 8 Quarters
Quarterly Detail
| Quarter | Report Date | Est EPS | Actual EPS | Surprise % | Result |
|---|---|---|---|---|---|
| Q1 2026 | Apr 21, 2026 | 2.11 | 2.50 | +18.67% | Beat |
| Q4 2025 | Jan 22, 2026 | 2.27 | 2.53 | +11.57% | Beat |
| Q3 2025 | Oct 21, 2025 | 1.99 | 2.40 | +20.70% | Beat |
| Q2 2025 | Jul 22, 2025 | 1.92 | 2.19 | +14.08% | Beat |
| Q1 2025 | Apr 22, 2025 | 1.73 | 1.81 | +4.41% | Beat |
| Q4 2024 | Jan 23, 2025 | 1.79 | 2.21 | +23.73% | Beat |
| Q3 2024 | Oct 17, 2024 | 1.64 | 1.84 | +12.25% | Beat |
| Q2 2024 | Jul 18, 2024 | 1.54 | 1.78 | +15.51% | Beat |
Recent Guidance Mentions (8-K)
- May 4, 2026 · 8-K
the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any 4141 EXHIBIT 10.1 such regulations or other guidance that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, in the event that following the Effective Date the Administrator determi
View 8-K filing → - May 4, 2026 · 8-K
ntrary, in the event that following the Effective Date the Administrator determines that any Award may be subject to Section 409A of the Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the Effective Date), the Administrator may adopt such amendments to the Plan and the applicable Program a
View 8-K filing → - May 4, 2026 · 8-K
he intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and related Department of Treasury guidance and thereby avoid the application of any penalty taxes under such Section. Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of “nonqual
View 8-K filing → - Apr 21, 2026 · 8-K
remain deeply committed to supporting customers globally in their pursuit of the quintuple aim: achieving better patient outcomes, improving patient and care team experiences, lowering the total cost to treat, and expanding access to high quality, minimally invasive care.” 2026 Financial Outlook The Company expects the following results for the full year of 2
View 8-K filing → - Apr 21, 2026 · 8-K
cial outlook provided above includes forward-looking, non-GAAP financial measures, which management uses in measuring performance. We do not provide a reconciliation of non-GAAP outlook measures to corresponding GAAP measures on a forward-looking basis, because we are unable to predict with reasonable certainty the exact timing and ultimate outcome of certain
View 8-K filing → - Apr 21, 2026 · 8-K
y is or may become a party; adverse publicity regarding the Company and the safety of the Company’s products and adequacy of training; the impact of changes to tax legislation, guidance, and interpretations; changes in tariffs, trade barriers, and regulatory requirements (including changes to tariffs imposed by the U.
View 8-K filing →
Data updated May 25, 2026 · source: Yahoo Finance via yfinance